tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market

Resmed (RMD) Financial Statements

Compare
1,154 Followers

Resmed Financial Overview

Resmed's market cap is currently $37.88B. The company's EPS TTM is $2.55; its P/E ratio is 26.56; and it has a dividend yield of 0.92%. Resmed is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $2.72. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 5.15B$ 4.69B$ 4.22B$ 3.58B$ 3.20B
Gross Profit$ 3.05B$ 2.66B$ 2.36B$ 2.02B$ 1.84B
Operating Income$ 1.69B$ 1.32B$ 1.13B$ 1.00B$ 903.68M
EBITDA$ 1.91B$ 1.53B$ 1.36B$ 1.18B$ 1.10B
Net Income$ 1.40B$ 1.02B$ 897.56M$ 779.44M$ 474.50M
Balance Sheet
Cash & Short-Term Investments$ 1.21B$ 238.36M$ 227.89M$ 273.71M$ 295.28M
Total Assets$ 8.17B$ 6.87B$ 6.75B$ 5.10B$ 4.73B
Total Debt$ 851.81M$ 873.93M$ 1.58B$ 917.55M$ 793.72M
Net Debt$ -357.64M$ 635.57M$ 1.35B$ 643.84M$ 498.44M
Total Liabilities$ 2.21B$ 2.01B$ 2.62B$ 1.74B$ 1.84B
Stockholders' Equity$ 5.97B$ 4.86B$ 4.13B$ 3.36B$ 2.89B
Cash Flow
Free Cash Flow$ 1.66B$ 1.29B$ 559.30M$ 195.11M$ 619.89M
Operating Cash Flow$ 1.75B$ 1.40B$ 693.30M$ 351.15M$ 736.72M
Investing Cash Flow$ -200.04M$ -269.78M$ -1.16B$ -229.92M$ -158.46M
Financing Cash Flow$ -606.25M$ -1.12B$ 422.87M$ -128.36M$ -764.63M
Currency in USD

Resmed Earnings and Revenue History

Resmed Debt to Assets

Resmed Cash Flow

Resmed Forecast EPS vs Actual EPS